Nonclinical Study Protocol Design and Data Evaluation

Testing Laboratory Selection and Study Placement and Monitoring

Regulatory Strategy and GLP Compliance

Design of Follow-Up Studies to Clarify Initial Toxicology Study Findings 

Negotiation with FDA and EPA on Issues of Concern

SOP Development

Risk Assessment of:

• Pharmaceuticals

• Cosmetics

• Environmental and Workplace Chemicals

• Pesticides

• Physical Agents (e.g., rf Radiation, Electromagnetic Fields)

• Medical Devices

Consumer Product Safety Evaluation; Ingredient and Formulation Review

Evaluation of Safety Issues for Product Candidates or Existing Products

Literature Search and Review

Journal Article Manuscript Preparation and Editing

Position Paper and Expert Report Preparation

Review and Critique of Epidemiological Studies

Evaluation of:

• Poisoning,

• Overdose,

• Drug- or Alcohol-Related Impairment

Interpretation of Forensic Lab Tests, including:

• Interpretation of Workplace Drug Testing Results,

• Blood and Breath Alcohol Results,

• Postmortem Lab Test Results

Evaluation of Therapeutic Drug Use for:

• Drug Interactions,

• Adverse Drug Effects,

• Interpretation of Therapeutic Drug Monitoring Results

Litigation Support and Strategy

Identification and Evaluation of Experts in Toxicology or Pharmacology